Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-24-016870

Options or other derivatives

  • Director acquired 45,832 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Reeve Emma Director 2024-06-12 Grant or award · Stock Option (right to buy) +45,832 45,832 D
Loading xslF345X05/form4-06142024_080619.xml…